Abstract 2845
Background
Adolescents and young adults (AYA) with cancer represent a unique demographic with distinctive developmental and psychosocial pressures. We sought to understand the baseline psychosocial needs of AYAs compared to case matched older adults at diagnosis using the Canadian Problem Checklist (CPC) and the Psychosocial Screen for Cancer - Revised (PSSCAN-R). The CPC is a tool to identify patient concerns in six domains: emotional, practical, spiritual, social, informational and physical. The PSSCAN-R is a validated tool to assess psychosocial needs and distress.
Methods
All AYA patients who completed the CPC and PSSCAN-R within 6 months of their cancer diagnosis between 2011-2016 in the province of British Columbia, Canada were included in the study. Baseline demographics were collected through retrospective chart review. A 3:1 case match based on gender, primary tumor site and metastatic status was performed with older adults (>40 years old) and AYA (18-40 years old). Statistical analysis was undertaken through Chi squared and Fisher’s exact test.
Results
2045 AYAs were case matched by common AYA tumor sites with 6050 older adults. Top five tumor sites were breast (20.4%), lymphoma (11.5%), gastrointestinal (10.8%), thyroid (10.6%), cervix/endometrium (8.0%). 61.9% were female and 12.1% had metastatic disease at diagnosis. The top 6 concerns for AYAs (% AYA, % older adults) were: fear/worry (56.6, 42.9) understanding of illness (47.6, 41.4), sleep (35.2, 28.9), sadness (34.1, 20.0), finances (33.8, 15.0), school/work (33.7, 10.5), all p < 0.01. AYAs reported higher anxiety at baseline (% AYA, % older adults): subclinical (26.0, 19.9), clinical (26.6, 17.1), p < 0.01.
Conclusions
Significant differences in baseline psychosocial needs for AYAs exist across multiple domains. Specifically, higher emotional, financial, school/work distress and baseline anxiety scores. Tailored support with early focus on these domains would benefit this unique and under-served population.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1757 - Development of chimeric antigenic receptor (CAR) against VEGFR2 for solid tumor treatment
Presenter: Li-Shuang Ai
Session: Poster Display session 1
Resources:
Abstract
4156 - Triple blockade of EGFR, MEK and PD-L1 as effective antitumor treatment in PD-L1 overexpressing, MEK inhibitor resistant colon cancer cells.
Presenter: Nunzia Matrone
Session: Poster Display session 1
Resources:
Abstract
2949 - EGFR-mediated PD-L1 upregulation in HER2+ breast cancer (BC) cell line models
Presenter: Nicola Gaynor
Session: Poster Display session 1
Resources:
Abstract
4270 - The impact of cortisol on immune cells and its effect on cancer-immune cells co-culture in a 3D spheroid of ovarian cancer
Presenter: Maysa Al-natsheh
Session: Poster Display session 1
Resources:
Abstract
1568 - Application of sonoporation to increase anticancer drug efficacy in 2D and 3D NSCLC cell cultures
Presenter: Vilma Petrikaite
Session: Poster Display session 1
Resources:
Abstract
5400 - Tr1-like cells in human peripheral blood are part of the T effector memory pool and are preferentially stimulated via CD55
Presenter: Iniobong Charles
Session: Poster Display session 1
Resources:
Abstract
5817 - Functional analysis of tumor infiltrating lymphocytes in triple negative breast cancer focusing on granzyme B
Presenter: Hitomi Kawaji
Session: Poster Display session 1
Resources:
Abstract
2287 - Aberrant glycolysis associates with inflammatory tumor microenvironment and promotes metastasis in triple-negative breast cancer
Presenter: Chengwei Lin
Session: Poster Display session 1
Resources:
Abstract
735 - Anti-cancer effects of differentiation-inducing factor-1 in triple negative breast cancer.
Presenter: Fumi Tetsuo
Session: Poster Display session 1
Resources:
Abstract
2105 - The Inhibitory Effect in Oral Squamous Cell Carcinoma Cells by Knocking down Matrix Metalloproteinase 9
Presenter: Xinyan Zhang
Session: Poster Display session 1
Resources:
Abstract